Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
OR3A4 was upregulated in DLBCL and tied to poor prognosis
Key clinical point: DLBCL patients with high OR3A4 expression suffered from poor prognosis.
Major finding: FOXM1-induced upregulation of OR3A4 enhances DLBCL via Wnt/beta-catenin signaling.
Study details: Genetic study of tissue specimens from DLBCL patients and DLBCL cell lines.
Disclosures: The authors declared that they had no competing interests.
Citation:
Meng H et al. Experimental and Molecular Pathology. 2020;115:doi.org/10.1016/j.yexmp.2020.104451.